Long-term Outcome of AIDS-related Primary Central Nervous System Lymphoma Treated With High Dose Methotrexate and Combined Antiretroviral Therapy (LCPVIH)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

AIDS Related Lymphoma
Central Nervous System Lymphoma

Treatments

Other: Retrospective survival analysis

Study type

Observational

Funder types

NETWORK

Identifiers

NCT03690895
NI_2015_2_AMR

Details and patient eligibility

About

This study aims at describing survival rates over time (Kaplan-Meier estimator) in patients suffering from AIDS-related primary central nervous system lymphoma who were diagnosed from 1996 to 2014 and treated with infusions of high-dose methotrexate and combined antiretroviral therapy.

Enrollment

51 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HIV infection
  • AIDS-related primary central nervous system lymphoma
  • treated with at least one infusion of methotrexate and combine antiretroviral therapy

Exclusion criteria

prior non-Hodgkin lymphoma

Trial design

51 participants in 1 patient group

Cases
Treatment:
Other: Retrospective survival analysis

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems